Maya Gulubova

Maya Gulubova


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2009 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
MGMaya Gulubova
Maya Gulubova
Tatyana VlaykovaTatyana Vlaykova
Tatyana Vlaykova

30 September 2012 in Wiener Medizinische Wochenschrift
Verified
Journal Article
Closed access
PDF file
GTGeorgi Tchernev
Georgi Tchernev
PPPlamen Kolev Penev
Plamen Kolev Penev
PNPietro Nenoff
Pietro Nenoff
LZLiliya Georgieva Zisova
Liliya Georgieva Zisova
JCJosé Carlos Cardoso
José Carlos Cardoso
Nobuo KanazawaNobuo Kanazawa
Nobuo Kanazawa



4 May 2014 in Biotechnology & Biotechnological Equipment
Verified
Journal Article
Open access
MGMaya Gulubova
Maya Gulubova
KIKoni Ivanova
Koni Ivanova
JAJulian Ananiev
Julian Ananiev
JGJulieta Gerenova
Julieta Gerenova
AZAleksandar Zdraveski
Aleksandar Zdraveski
Tatyana VlaykovaTatyana Vlaykova
Tatyana Vlaykova
Thyroid cancer is one of the five most common cancers in the age between 20 and 50 years. Many factors including the potent angiogenic vascular endothelial growth factor (VEGF) and different dendritic cell types are known to be related to thyroid tumourogenesis. The study was performed to address the expression of VEGF and microvessel density in thyroid cancers and to evaluate the effect of VEGF expression in thyroid tumour cells on the dendritic cells. We investigated 65 patients with different types of thyroid carcinomas: papillary (PTC), oncocytic (OTC), follicular (FTC) and anaplastic (ATC), immunohistochemically with antibodies against VEGF, CD1a, CD83, S100 and CD31. Our results suggest that the expression of VEGF is significantly more often in PTC than ATC (92.3% vs. 60.0%, p = 0.025). The microvessel density marked with CD31 in the tumour border of PTC was significantly higher as compared to FTC (p = 0.039), but not to ATC and OTC (p = 0.337 and 0.134). We found that CD1a- and CD83-positive cells were dispersed with variable density and in OC CD31+ vessel numbers were positively correlated with CD83+ dendritic cells in tumour stroma (R = 0.847, p = 0.016). We did not find statistically significant associations of the survival of patients with PTC after the surgical therapy with VEGF expression and MVD. In conclusion we may state that VEGF expression in tumour cells of thyroid cancer can induce neovascularization and suppress dendritic cells.

16 November 2006 in International Journal of Colorectal Disease
Verified
Journal Article
Closed access
PDF file
MGMaya Gulubova
Maya Gulubova
IMIrena M. Manolova
Irena M. Manolova
Tatyana VlaykovaTatyana Vlaykova
Tatyana Vlaykova
MPMargarita Prodanova
Margarita Prodanova
JJJovcho P. Jovchev
Jovcho P. Jovchev